American Century Companies’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

American Century Companies’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,477	Closed	-$533K	–	2920
2023 Q2	$533K	Buy	+11,477	New	+$397K	﹤0.01%	2192
2023 Q1	–	Sell	-12,369	Closed	-$386K	–	2709
2022 Q4	$386K	Buy	+12,369	New	+$403K	﹤0.01%	2137

American Century Companies's DICE Position: Q3 2023 in Review

American Century Companies sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 11,477 shares — an estimated $533K sold.

American Century Companies first reported a position in DICE in Q4 2022 and held it in 2 quarters. The position peaked at $533K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

American Century Companies reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
American Century Companies sold 11,477 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $533K.
American Century Companies first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
American Century Companies's DICE Therapeutics, Inc. Common Stock position peaked at $533K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.